BOPA Corporate Membership Information **PUBLISHED**

Document explaining corporate membership information with answers to FAQ’s.

 

Available here 

Latest News

By BOPA research committee on 10th February 2025

SURVEY: Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma

Help Improve Bispecific Antibody Delivery for Multiple Myeloma Patients! The Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma was published November 2024. Created by the…

Read article
By BOPA on 3rd February 2025

UKPPL Board and BOPA Webinar (Wednesday12th Feb 2025): Collaborative Pharmacy Professional Leadership

Wednesday 12th February 2025 16:00 GMT   ‘Enabling us to be the best that pharmacy can be’ webinars will be held across the UK from 3rd to 25th February 2025,…

Read article
By BOPA Committee on 31st January 2025

Publication update: National SACT regimen specific consent forms for bladder cancer

Dear All,   National SACT regimen specific bladder cancer forms have been reviewed and updated. All forms can be found here: www.cruk.org/sact_consent. Please share this update with your clinical teams…

Read article
By Clayton Wong on 26th January 2025

BOPA E&T and Research groups would like to hear from you

Have you listened to or attended the BOPA podcasts and webinar series last year? What topics do you want to feature in the future? Over the past few years, BOPA…

Read article